πŸ‡ΊπŸ‡Έ FDA
Patent

US 7795209

Anti-angiogenic methods and compositions

granted A61KA61K38/00A61P

Quick answer

US patent 7795209 (Anti-angiogenic methods and compositions) held by Sangamo Biosciences, Inc. expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61P, A61P27/02, A61P35/00